Total for the last 12 months
number of access : ?
number of downloads : ?
ID 119076
Author
Hanyuda, Akiko National Cancer Center Institute for Cancer Control|Keio University
Goto, Atsushi National Cancer Center Institute for Cancer Control|Yokohama City University
Katagiri, Ryoko National Cancer Center Institute for Cancer Control
Koyanagi, Yuriko N. Aichi Cancer Center
Nakatochi, Masahiro Nagoya University
Sutoh, Yoichi Iwate Tohoku Medical Megabank
Nakano, Shiori National Cancer Center Institute for Cancer Control
Oze, Isao Aichi Cancer Center
Ito, Hidemi Aichi Cancer Center|Nagoya University
Yamaji, Taiki National Cancer Center Institute for Cancer Control
Sawada, Norie National Cancer Center Institute for Cancer Control
Iwagami, Masao National Cancer Center Institute for Cancer Control|University of Tsukuba|London School of Hygiene and Tropical Medicine
Kadota, Aya Shiga University of Medical Science
Koyama, Teruhide Kyoto Prefectural University of Medicine
Ikezaki, Hiroaki Kyushu University
Tanaka, Keitaro Saga University
Takezaki, Toshiro Kagoshima University
Imoto, Issei Aichi Cancer Center Research Institute KAKEN Search Researchers
Suzuki, Midori Aichi Cancer Center Research Institute
Momozawa, Yukihide RIKEN
Takeuchi, Kenji Nagoya University
Narita, Akira Tohoku University
Hozawa, Atsushi Tohoku University
Kinoshita, Kengo Tohoku University
Shimizu, Atsushi Iwate Tohoku Medical Megabank
Tanno, Kozo Iwate Medical University
Matsuo, Keitaro Nagoya University|Aichi Cancer Center
Tsugane, Shoichiro National Institutes of Biomedical Innovation, Health and Nutrition|National Cancer Center Institute for Cancer Control
Wakai, Kenji Nagoya University
Sasaki, Makoto Iwate Medical University
Yamamoto, Masayuki Tohoku University
Iwasaki, Motoki National Cancer Center Institute for Cancer Control
Content Type
Journal Article
Description
Observational studies suggest that abnormal glucose metabolism and insulin resistance contribute to colorectal cancer; however, the causal association remains unknown, particularly in Asian populations. A two-sample Mendelian randomisation analysis was performed to determine the causal association between genetic variants associated with elevated fasting glucose, haemoglobin A1c (HbA1c), and fasting C-peptide and colorectal cancer risk. In the single nucleotide polymorphism (SNP)-exposure analysis, we meta-analysed study-level genome-wide associations of fasting glucose (~ 17,289 individuals), HbA1c (~ 52,802 individuals), and fasting C-peptide (1,666 individuals) levels from the Japanese Consortium of Genetic Epidemiology studies. The odds ratios of colorectal cancer were 1.01 (95% confidence interval [CI], 0.99–1.04, P = 0.34) for fasting glucose (per 1 mg/dL increment), 1.02 (95% CI, 0.60–1.73, P = 0.95) for HbA1c (per 1% increment), and 1.47 (95% CI, 0.97–2.24, P = 0.06) for fasting C-peptide (per 1 log increment). Sensitivity analyses, including Mendelian randomisation-Egger and weighted-median approaches, revealed no significant association between glycaemic characteristics and colorectal cancer (P > 0.20). In this study, genetically predicted glycaemic characteristics were not significantly related to colorectal cancer risk. The potential association between insulin resistance and colorectal cancer should be validated in further studies.
Journal Title
Scientific Reports
ISSN
20452322
Publisher
Springer Nature
Volume
13
Start Page
7052
Published Date
2023-04-29
Rights
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences